Changes in specific antibody titers and interferon gamma levels after an Omicron BA.4/BA.5-Adapted Bivalent Booster

Not Applicable

• Conditions: COVID-19

• Registration Number: JPRN-UMIN000049273
• Lead Sponsor: Fukuoka City Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-10
• Study Completion: 2022-12-31
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in spike-specific antibody titers and interferon gamma levels one month after an Omicron BA.4/BA.5-Adapted Bivalent Booster.

Secondary Outcome Measures

Name	Time	Method
The relation between the degree of adverse reactions and the strength of the immune response to an Omicron BA.4/BA.5-Adapted Bivalent Booster.